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Abstract. 
DNA damage response mechanisms encompass pathways of DNA repair, cell cycle 
checkpoint arrest and apoptosis. Together, these mechanisms function to maintain genomic 
stability in the face of exogenous and endogenous DNA damage. ATM is activated in 
response to double strand breaks and initiates cell cycle checkpoint arrest. Recent studies in 
human fibroblasts have shown that ATM also regulates a mechanism of end-processing that 
is required for a component of double strand break repair. Human fibroblasts rarely 
undergo apoptosis after ionising radiation and, therefore, apoptosis is not considered in our 
review. The dual function of ATM raises the question as to how the two processes, DNA 
repair and checkpoint arrest, interplay to maintain genomic stability. In this review, we 
consider the impact of ATM’s repair and checkpoint functions to the maintenance of 
genomic stability following irradiation in G2. We discuss evidence that ATM’s repair 
function plays little role in the maintenance of genomic stability following exposure to 
ionising radiation. ATM’s checkpoint function has a bigger impact on genomic stability but 
strikingly the two damage response pathways co-operate in a more than additive manner. In 
contrast, ATM’s repair function is important for survival post irradiation.  
 
Introduction.
 
Cells have evolved elaborate damage response mechanisms to maintain genome stability. 
During the progression to carcinogenesis, the damage response pathways frequently 
become down regulated which enhances the opportunity to generate genomic instability 
and unrestricted cell growth. The damage response mechanisms include processes of DNA 
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repair, cell cycle checkpoint arrest and apoptosis. A chromosomal translocation, which is 
the subject of this special issue, represents a particular form of chromosomal instability that 
is likely to be heritable since it has the potential to escape recognition by the damage 
response pathways. Most chromosomal translocations arise through aberrant processing of 
a DNA double strand break (DSB). In this article, we focus on two damage response 
processes, namely DSB repair and DSB-induced cell cycle checkpoint arrest, that play 
critical roles in preventing chromosomal instability caused by the induction of DSBs. We 
briefly overview the two damage response processes and discuss our recent findings aimed 
at examining the interplay between the two processes.  
 
Overview of radiation-induced DNA damage response mechanisms . 
Homologous recombination (HR) and DNA non homologous end-joining (NHEJ) represent 
the two major DSB repair mechanisms in mammalian cells [1-3]. HR functions primarily to 
repair lesions at the replication fork, playing only a minor role in repairing DSBs that arise 
elsewhere in the genome, as suggested by the minor sensitivity of cell lines defective in HR 
to ionising radiation (IR). In contrast, NHEJ repairs DSBs at all cell cycle stages and 
mutants lacking NHEJ components are dramatically radiosensitive [4]. Since here we will 
consider chromosomal instability arising from DSBs induced by IR, our focus will be on 
NHEJ. Two DNA damage signal transduction responses have been characterised, which are 
initiated by two distinct but related phosphatidylinositol 3 (PI 3)-kinase like kinases 
(PIKKs) [5]. Ataxia telangiectasia mutated (ATM) is activated by the presence of DSBs 
whilst Ataxia telangiectasia and Rad3 related (ATR) is activated by single stranded regions 
of DNA. Once activated both kinases phosphorylate multiple overlapping substrates and 
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initiate overlapping although not identical damage responses [5]. These damage responses 
include aspects of DNA repair, cell cycle checkpoint arrest and apoptosis. Here, our focus 
lies on ATM since it is the major kinase activated by DSBs. 
 
NHEJ. 
Six core components of NHEJ, which assemble as two distinct complexes, have now been 
identified [1,2]. The DNA-dependent protein kinase complex (DNA-PK) encompasses the 
heterodimeric Ku protein with subunits, Ku70 and Ku80, and a large catalytic subunit, 
DNA-PKcs [6]. The Ku heterodimer has two pillars, a head and a base, with a central core 
that allows the passage of double stranded DNA [7].  Once Ku encircles double stranded 
DNA, it recruits DNA-PKcs resulting in activation of DNA-PK kinase activity. Although 
the role of the kinase activity remains to be fully elucidated, current evidence suggests that 
it regulates the process and facilitates processing of DNA ends (see below) [8]. The 
assembled DNA/DNA-PK complex recruits the second complex, which includes DNA 
ligase IV [9]. Until recently, this complex was thought to encompass two tightly associated 
proteins, DNA ligase IV and Xrcc4. Recently, however, a third protein, designated XLF or 
Cernunnos, which has homology to Xrcc4, has been identified and shown to co-associate 
with the DNA ligase IV/Xrcc4 complex [10,11]. These proteins represent the core NHEJ 
proteins and loss of any of them confers marked radiosensitivity and defective DSB 
rejoining. Loss of DNA-PKcs has a less dramatic impact on DSB rejoining compared to 
loss of the other core components and we, therefore, consider it to be a facilitating but non-
essential NHEJ component [12]. In support of such a role, some species including S. 
cerevisiae or Schizosaccharomyces pombe, carry out NHEJ efficiently despite lacking a 
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DNA-PKcs homologue. DNA-PKcs does not simply represent a late evolutionary addition 
to NHEJ, however, as homologues have been found in arthopods [13]. 
 Most DSBs rarely arise exogenously or endogenously as 5’P and 3’OH ends, the 
prerequisite for ligation by all known DNA ligases. Thus, the majority of DNA ends must 
undergo end-processing prior to ligation. Roles for polynucleotide kinase (PNK), DNA 
polymerase µ and DNA polymerase λ in end-processing have been reported [14,15]. More 
recently, Artemis has been reported to play a role in modifying a subset of DNA ends prior 
to ligation by NHEJ [12]. Artemis is a member of the β-lactamase superfamily and has 5’ 
to 3’ exonuclease activity. In the presence of DNA-PKcs, Artemis can also function as a 5’ 
and 3’ endonuclease and can cleave hairpin junctions [16]. In distinction to cells lacking 
core NHEJ components, Artemis-defective cells rejoin the majority of IR-induced DSBs 
normally but fail to rejoin approximately 10 % of X-ray induced DSBs [12] (Fig 1). 
Interestingly, the Artemis-dependent DSBs are those rejoined with slow kinetics in normal 
cells. Significantly, Artemis is dispensable for rejoining DSBs induced by etoposide, a 
topoisomerase II inhibiting anti-cancer drug. Since etoposide-induced DSBs are unlikely to 
have associated base and sugar damage, it has been proposed that Artemis functions to 
process a subset of DNA ends, although the precise structure of these ends remains to be 
determined [17]. Intriguingly, Artemis-dependent DSB rejoining also requires ATM, the 
Mre11/Rad50/Nbs1 (MRN) complex, 53BP1 and H2AX [12].  These findings demonstrate 
an interplay between NHEJ and ATM-dependent signalling. 
 
Cell cycle checkpoint arrest. 
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Damage response checkpoints have been identified at the G1/S and G2/M boundaries as 
well as during S phase and potentially in mitosis [18]. ATM and ATR are upstream 
activators of damage-inducible checkpoint arrest [19]. The prevailing evidence suggests 
that in response to a DSB, ATM either directly or via Chk2 phosphorylates p53, which 
transcriptionally activates the Cdk inhibitor, p21, which serves to prevent entry from G1 
into S phase [18]. G2/M arrest functions via the transducer kinases, Chk1 and Chk2. There 
is strong evidence that ATM and ATR primarily phosphorylate Chk2 and Chk1, 
respectively. However, the precise overlap between the PIKKs and transducer kinases is 
still unclear. The Cdc25 phosphatases, which are required to remove inhibitory Cdk 
phosphorylation and hence promote progression from G2 into mitosis, are phosphorylation 
targets of Chk1 and Chk2. The precise mechanisms whereby phosphorylation regulates the 
activity of the phosphatases are currently unclear but include inhibition of activity and 
ubiquitin mediated degradation [18]. 
 
Apoptosis.  
Two pathways of apoptosis have been described, mitochondria-mediated apoptosis and a 
process initiated by receptor signalling. The onset of apoptosis after DNA damage is highly 
cell type dependent with some cell types having a low threshold for activation and others 
rarely undergoing apoptosis. In this chapter, we will mainly consider the response of 
primary human fibroblasts, which rarely undergo apoptosis after exposure to IR, but instead 
undergo permanent cell cycle arrest. Thus, we will neither consider the process of 
apoptosis, nor its impact to any extent. 
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The role of ATM in DNA damage response processes after exposure to IR. 
Ataxia telangiectasia (A-T) is a human disorder conferred by mutations in ATM [20]. A-T  
cell lines have long been known to be defective in IR-induced cell cycle checkpoint arrest, 
failing to induce G1/S phase arrest, intra-S phase arrest, which confers the well known 
radioresistant DNA synthesis phenotype, and G2/M phase arrest [19]. More recently, A-T 
cells have also been shown to display a DSB repair defect identical to that shown by 
Artemis-defective cells [12,21]. Epistasis-like analysis using an ATM inhibiting drug has 
demonstrated that ATM and Artemis lie in a common pathway for DSB repair. 
Additionally, Artemis is an ATM phosphorylation target [12,22-24]. The model proposed is 
that ATM is required for Artemis-dependent end-processing and hence Artemis-dependent 
DSB repair [12].  Thus, ATM has dual functions in the response to DSBs, activation of cell 
cycle checkpoint arrest and activation of an end-processing mechanism required for a 
component of DSB repair [25]. Intriguingly, as mentioned above, the DSBs that are 
rejoined in an ATM/Artemis-dependent manner are those rejoined with slow kinetics in 
control cells. Thus, those DSBs that require ATM for rejoining are those that gain most 
benefit from ATM-dependent checkpoint arrest. Here, we discuss the contribution of these 
two distinct ATM regulated DNA damage responses to the maintenance of chromosomal 
stability. 
 
Checkpoint arrest and DNA repair co-operate in a more than additive manner to 
maintain chromosome stability. 
Checkpoint arrest after DNA damage has two potential impacts. It allows additional time 
for repair to take place before cell cycle progression and it can permanently prevent 
 8
proliferation of severely damaged cells. Thus, loss of checkpoints enhances chromosome 
aberration formation (breaks per cell) in mitotic cells consistent with the notion that 
checkpoints serve to prevent cells with an excessive level of damage from entering 
mitosis[26 ]. Although one study has suggested that Artemis-defective cells fail to maintain 
arrest at the G2/M checkpoint after IR [23], we have observed Artemis-defective cells to be 
checkpoint proficient and indeed to maintain a prolonged G2/M arrest after IR, compared to 
control cells, consistent with their DSB repair defect (Deckbar, manuscript submitted). 
Thus, we argue that Artemis represents a cell line defective in ATM-dependent DSB repair 
but proficient for ATM-dependent cell cycle checkpoint arrest. Although Chk2 is 
phosphorylated by ATM in response to DSBs, we and others have observed that Chk2-
deficient cells effect G2/M checkpoint arrest proficiently after IR (although they have been 
reported in other studies to be defective in the maintenance of this arrest) [27,28](Deckbar, 
manuscript submitted) . The failure of Chk2-deficient cells to arrest is most likely due to 
overlapping functions of Chk1 and Chk2 [29]. Consistent with this notion, treatment of 
cells irradiated in G2 with a Chk1/Chk2 inhibiting drug abrogated ATM’s G2/M 
checkpoint arrest but had no impact on ATM’s repair function, thereby providing a repair 
proficient but checkpoint-defective situation. Using these tools, we recently undertook a 
study to examine the impact of ATM’s repair versus its checkpoint function on the 
maintenance of chromosome stability following irradiation in G2 (Deckbar, manuscript 
submitted). We examined chromosome breaks as a monitor of chromosome instability. We 
found that following irradiation in G2 (and using conditions that prevented S phase cells 
progressing to G2 or mitosis), the number of chromosome breaks per cell was elevated to 
similar extents in cells lacking either ATM’s repair or checkpoint function. Abrogation of 
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both, either by examination of A-T cell lines or by treatment of Artemis cells with the 
Chk1/Chk2 inhibiting drug resulted, as might be anticipated, in a further increase in 
chromosome aberrations per cell. However, the very impact of checkpoint arrest results in 
fewer cells reaching mitosis. Thus, we argued that simply estimating the number of 
chromosome breaks per cell underestimates the impact of checkpoint arrest. We, therefore, 
attempted to estimate the total number of mitotic chromosome breaks by considering the 
number of mitotic cells in addition to the number of chromosome breaks per cell.  Firstly, 
we estimated the number of cells entering mitosis (ie the magnitude of checkpoint arrest) 
by FACs analysis. We then estimated the total number of mitotic breaks based on the 
estimated number of mitotic cells times the number of breaks per cell. When the ability of 
checkpoints to prevent mitotic entry was considered, we found that Artemis-defective cells 
had no elevated chromosome instability relative to control cells whereas A-T cells have a 
level of instability at least ten fold greater. In other words, although the repair defect has the 
potential to lead to elevated chromosome breaks, checkpoint arrest efficiently prevents this 
taking place (Fig 2).When the checkpoint inhibiting drug was added to control or Artemis-
defective cells, enhanced total chromosome aberrations were observed, partially for control 
cells and to a level similar to A-T cells for Artemis-deficient cells. Thus, loss of checkpoint 
arrest has a greater impact on repair-defective cells relative to repair proficient cells. Thus, 
the dual impact of ATM’s repair and checkpoint functions is greater than the sum of the 
two individual impacts (Fig 2). We conclude that ATM’s repair and checkpoint functions 
act synergistically to maintain chromosome stability following irradiation in G2. Moreover, 
our findings show, perhaps surprisingly, that loss of ATM’s repair function alone makes 
little contribution to genomic instability. 
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 Survival represents another important end point following exposure to IR. 
Previously, we showed that following irradiation in G0 phase, Artemis- and ATM-defective 
cells show similar marked radiosensitivity [12]. We also examined survival of 
exponentially growing cells, which we estimate contain approximately 20 % G2 phase 
cells. Since the survival curves provide no evidence for a resistant component, we conclude 
that G2 cells display similar radiosensitivity to G1 cells. Importantly, under these 
conditions, Artemis-defective cells display marked radiosensitivity, demonstrating that 
ATM’s repair function contributes markedly to survival (Deckbar, manuscript submitted). 
 To summarise, our findings suggest that ATM’s repair function makes little 
contribution to chromosome stability but has a significant impact on survival post IR. In 
contrast, ATM’s checkpoint function provides significant protection against chromosome 
instability. We have been unable to monitor the impact on survival since abrogation of 
Chk1 causes cell lethality but the similar survival level of ATM- and Artemis-defective 
cells suggests that checkpoints do not appreciably contribute to radioresistance at least in a 
repair-deficient background. Strikingly, however, loss of both damage response processes 
causes a more than additive impact on chromosome instability. To date, these studies have 
only examined the impact of repair in G2 and the G2/M checkpoint. Although the relative 
contribution of ATM’s repair versus checkpoint function may differ slightly following 
irradiation in G1, we anticipate that a similar synergistic effect will be observed.  
 
Other studies examining the interplay between damage response pathways. 
Mouse studies have provided an important and complementary approach to examine 
interactions between damage response pathways. Importantly, mouse studies allow an 
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analysis of cancer frequency, which is clearly an important endpoint. However, a limitation 
is that mouse studies do not allow a precise dissection and separation of distinct endpoints 
such as chromosomal instability and survival. The majority of multiple pathway analysis 
using mice has focused on genetic crosses involving p53 (see for example [30-34]). Since 
p53 has critical roles in apoptosis and cell cycle checkpoint arrest, the interplay between 
defined pathways cannot be established. Nonetheless, these studies have demonstrated that 
joint defects in DNA repair pathways and p53 confer elevated tumour incidence. Of 
relevance is the finding of pronounced tumour elevation when defects in p53 are combined 
with defects in any of the NHEJ proteins, including Artemis. Indeed, Artemis knock out 
mice display only a minor elevated cancer incidence, which is increased dramatically in a 
p53 knock out background [34]. Our findings, therefore, are consistent with the mouse 
studies, namely that DNA repair defects only confer mild genomic instability which is 
synergistic with checkpoint and/or apoptotic defects. Interestingly, cells from Artemis 
knock out mice were reported to display genomic instability monitored as chromosome 
aberrations per mitotic cell but clearly such cells did not progress to enhance tumour 
frequency dramatically, consistent with the notion that they are frequently removed by cell 
cycle checkpoint arrest and/or apoptosis [34].  
 
Clinical Significance. 
A-T is a disorder characterised by pronounced cancer predisposition [20]. Additionally, 
ATM mutations have been observed in tumours [35,36]. Additionally, a subset of Li 
Fraumeni patients, who also display pronounced cancer predisposition, have mutations in 
Chk2 [37]. Artemis is defective in RS-SCID1, a subset of severe combined 
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immunodeficiency patients whose cells display radiosensitivity [38]. A considerable 
number of Artemis-defective patients have now received bone marrow transplants, and 
subsequently are able to lead healthy lives. There is no reported cancer predisposition in 
such patients (NB Artemis patients with hypomorphic mutations show elevated frequency 
of EBV-associated tumours but this may be a consequence of their immune deficiency 
rather than elevated genomic instability) [39].  Although this analysis of patients has many 
limitations, the lack of marked cancer predisposition in Artemis patients is consistent with 
the lack of elevated chromosomal instability suggested from our cellular studies.  Further 
studies, will, however, be required to extend the significance of our cellular studies.  
Our studies may also be important for drug targeting. The development of drugs 
that target DSB repair pathways, particularly when used in conjunction with radiotherapy, 
has the potential to inhibit tumour growth with minimal genomic instability. Targets aimed 
at NHEJ components may, therefore, be more effective than targets aimed at ATM. 
 
Relevance to mechanisms generating chromosomal translocations. 
Here, we have discussed the interplay between ATM’s DSB repair and cell cycle 
checkpoint functions in generating chromosomal instability and survival. Chromosomal 
translocations are a particular form of chromosomal instability that may escape checkpoint 
arrest particularly if the translocations are balanced. However, most translocations arise 
concomitantly with acentric chromosome fragments, and thus our studies on chromosome 
instability will likely provide general rules for the generation of chromosomal 
translocations. Additionally, translocations involve some form of aberrant DNA repair and 
to date, our studies have focused on the interplay between ablated repair and checkpoint 
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functions. Future studies will need to evaluate the impact of hypomorphic mutations that 
may promote slow but inaccurate repair. Furthermore studies with mutants lacking Ku and 
other NHEJ components have demonstrated an increase in chromosome rearrangements, 
suggesting that DSBs that remain unrepaired by NHEJ may undergo aberrant forms of 
rejoining including telomere-break fusion events and aberrant homologous recombination 
[40]. Subsequent studies will be needed to address how such events contribute to the 
generation of translocations. 
 
 
 
Acknowledgements: 
We thank the people in our groups who contributed to this work. Financial support in the 
ML laboratory is provided by the Deutsche Forschungsgemeinschaft (LO 677/4-1) and the 
Bundesministerium für Bildung und Forschung via the Forschungszentrum Karlsruhe 
(Grant 02S8132) and via the Deutsche Zentrum für Luft und Raumfahrt e.V. (Grant 
50WB0017). The PAJ laboratory is supported by the Medical Research Council, the 
Human Frontiers Science Programme, the Primary Immunodeficiency Association, the 
Leukaemia Research Fund, the International Association for Cancer Research and an EU 
grant (FIGH-CT-200200207). 
 14
Figure Legends. 
 
Figure 1. Damage Responses induced by different classes of DNA DSBs. 
DSBs induce cell cycle checkpoint arrest and DSB repair. Checkpoint arrest by DSBs is 
ATM and Chk1/2 dependent. DSB repair is dependent upon NHEJ proteins and additional 
factors as indicated in the figure, depending upon the nature of the DSB. The most simple 
DSBs have 3’OH and 5’P ends, which is the prerequisite for ligation. Slightly more 
complex DSBs may have 3’P and 5’OH ends that require simple processing (most likely by 
PNK) prior to ligation. Other ends may be associated with sugar and base damage. Finally, 
at the furthest extreme, some radiation-induced DSBs are highly complex with multiple 
associated lesions including DSBs, SSBs and base damage in close proximity. The core 
NHEJ components alone (Ku, DNA-PKcs, Xrcc4, DNA ligase IV and XLF) are required to 
repair ~ 90 % of the DSBs. Additional components, as shown in the figure, are required to 
repair ~ 10 % of radiation-induced DSBs. The precise nature of the DNA end that requires 
the additional proteins and whether it represents a highly complex DSB or a specific class 
of DSBs is currently unclear. Thus, ATM regulates two independent functions in the 
response to DNA damage; Artemis deficiency solely results in a repair defect; abrogation 
of Chk1/2 causes uniquely a checkpoint defect.  
 
Figure 2. Impact of DNA repair and cell cycle checkpoint arrest on survival and genomic 
instability after irradiation. 
The figure focuses on the impact of irradiation in G2. The frequency of total mitotic 
chromosome breaks is taken as a monitor of genomic instability. Wild type cells are repair 
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and checkpoint proficient. Most cells arrest at the G2/M checkpoint until repair is 
completed. 2-8 h following exposure to 1 Gy, the few metaphases present have low 
numbers of chromosome break. Abrogation of Chk1/2 does not impact upon DNA repair.  
However, many cells progress to mitosis before repair has been completed. Thus, there are 
many metaphases with a slightly elevated number of chromosome breaks per metaphase 
compared to control cells and the total number of chromosome breaks is moderately 
increased. Artemis deficiency impairs DSB repair but efficient checkpoint arrest prevents 
cells entering mitosis. Thus, there are very few metaphases albeit with elevated 
chromosome breaks but the total number of chromosome breaks remains low.  Defects in 
ATM abrogate both DNA repair and checkpoint arrest. Thus, many cells with unrepaired 
DSBs enter mitosis causing a big increase in total chromosome breaks. The impact on 
survival is also shown. It is currently difficult to assess the impact of checkpoint abrogation 
on survival because Chk1 is required to stabilise replication forks. However, since ATM- 
and Artemis-deficient cells display similar radiosensitivity, we suggest that checkpoints 
have only a small impact on survival at least in a repair-defective background. The impact 
may be more manifest in a repair proficient background, however. 
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